Intracellular Th Stock Investor Sentiment

ITCI Stock  USD 85.65  0.94  1.09%   
Under 65% of Intracellular's investor base is looking to short. The analysis of overall sentiment of trading Intracellular Th stock suggests that many investors are alarmed at this time. Intracellular's investing sentiment shows overall attitude of investors towards Intracellular Th.

Panic Vs Confidence

35

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Intracellular's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Intracellular Th.

Intracellular Historical Sentiment

Although Intracellular's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Intracellular, such as negative comments on social media and news outlets, may cause fear in the market and push Intracellular's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Intracellular.
  

Intracellular Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Intracellular can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
a day ago at investing.com         
Intra-Cellular Therapies stock rated Outperform by Mizuho, with 13 percent stock rise post-earnings
Investing News at Macroaxis
a day ago at zacks.com         
Why Is Intra-Cellular Up 2.2 percent Since Last Earnings Report?
zacks News
six days ago at thelincolnianonline.com         
Intra-Cellular Therapies, Inc. Shares Purchased by Eagle Asset Management Inc.
news
six days ago at thelincolnianonline.com         
Disposition of 306 shares by Sharon Mates of Intracellular at 67.33 subject to Rule 16b-3
news
over a week ago at www.macroaxis.com         
Acquisition by Van Nostrand Robert L of 1567 shares of Intracellular subject to Rule 16b-3
Macroaxis News
over two weeks ago at gurufocus.com         
Suvretta Capital Management, LLC Increases Stake in KalVista Pharmaceuticals Inc
Gurufocus Stories at Macroaxis
over two weeks ago at investing.com         
Intra-cellular therapies president sells 3.69 million in stock
Investing News at Macroaxis
over two weeks ago at investing.com         
Disposition of 13371 shares by Halstead Michael of Intracellular at 88.17 subject to Rule 16b-3
Investing News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Aigen Investment Management LP Increases Stock Holdings in Intra-Cellular Therapies, Inc.
news
over two weeks ago at gurufocus.com         
FMR LLC Reduces Stake in Intra-Cellular Therapies Inc
Gurufocus Stories at Macroaxis
over two weeks ago at thelincolnianonline.com         
Disposition of 18714 shares by Halstead Michael of Intracellular at 36.89 subject to Rule 16b-3
news
over two weeks ago at www.macroaxis.com         
Disposition of 22869 shares by Halstead Michael of Intracellular at 23.94 subject to Rule 16b-3
Macroaxis News
over three weeks ago at simplywall.st         
Revenues Tell The Story For Intra-Cellular Therapies, Inc. As Its Stock Soars 26
Simply Wall St News at Macroaxis
over three weeks ago at globenewswire.com         
Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress
Macroaxis News: globenewswire.com
over three weeks ago at finance.yahoo.com         
Intra-Cellular bolsters Caplyta data with another Phase III win
Yahoo News
Far too much social signal, news, headlines, and media speculation about Intracellular that are available to investors today. That information is available publicly through Intracellular media outlets and privately through word of mouth or via Intracellular internal channels. However, regardless of the origin, that massive amount of Intracellular data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Intracellular news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Intracellular relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Intracellular's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Intracellular alpha.

Intracellular Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Riggs Rory B of 246 shares of Intracellular at 73.17 subject to Rule 16b-3
09/30/2024
2
Intra-Cellular Therapies Reports Third Quarter 2024 Financial Results, Provides Corporate Update and Raises 2024 Caplyta Sales Guidance
10/30/2024
3
Intra-Cellular Therapies Third Quarter 2024 Earnings Revenues Beat Expectations, EPS Lags
11/01/2024
4
JPMorgan Chase Co. Forecasts Strong Price Appreciation for Intra-Cellular Therapies Stock
11/04/2024
5
Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia
11/05/2024
6
Revenues Tell The Story For Intra-Cellular Therapies, Inc. As Its Stock Soars 26
11/07/2024
7
Disposition of 22869 shares by Halstead Michael of Intracellular at 23.94 subject to Rule 16b-3
11/12/2024
8
Disposition of 18714 shares by Halstead Michael of Intracellular at 36.89 subject to Rule 16b-3
11/13/2024
9
Disposition of 13371 shares by Halstead Michael of Intracellular at 88.17 subject to Rule 16b-3
11/14/2024
10
Acquisition by Van Nostrand Robert L of 1567 shares of Intracellular subject to Rule 16b-3
11/15/2024
11
Why Is Intra-Cellular Up 2.2 percent Since Last Earnings Report
11/29/2024

Complementary Tools for Intracellular Stock analysis

When running Intracellular's price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments